Order of the Supreme Court of India in the matter of Network of People Living With HIV/AIDS & Others Vs Union of India & Others dated 24/02/2025. The Supreme Court (SC), February 24, 2025 has directed all states to file their affidavits addressing concerns raised about antiretroviral therapy (ART) drugs …
The lead outside investigator on a crucial trial of two widely used anti-cholesterol drugs said in an e-mail message in July that Merck and Schering-Plough, the companies that make the drugs, were deliberately delaying the release of the trial results "to hide something." The companies did not release the preliminary …
Two widely prescribed cholesterol-lowering drugs, Vytorin and Zetia, may not work and should be used only as a last resort, a panel of four cardiologists has told an audience of more than 5,000 people at a major cardiology conference. Instead, doctors and patients should rely more heavily on older cholesterol-lowering …
Currently, there is a debate on what impact the implementation of the Trade Related Aspects of Intellectual Property Rights (TRIPS) in India would have on its pharmaceutical industry and health care. The debate hinges primarily on two major questions. First, will the new patent regime provide an impetus for innovation …
pharmaceutical giant GlaxoSmithKline is recalling its malaria drug Lapdap and has discontinued development of another malaria drug, Dacart, saying the drugs can lead to anaemia in some patients. Experts say the move is a setback to fight the disease. On February 29, Glaxo said its clinical trials had found that …
As the outbreak of yellow fever spreads from Brazil to its neighbouring countries, Argentina and Paraguay, who has said that the world's supply of vaccine against the disease is under extreme pressure. "At this point, our global emergency stockpile is depleted. We are very much on the edge of our …
Hundreds of Japanese people accidentally infected with hepatitis C between the 1970s and 1990s are to be awarded compensation from the government and the drug companies responsible. But thousands of others also affected by the scandal stand to get nothing.
Chief Minister Tarun Gogoi on Tuesday launched a new health scheme under which cancer patients in the State will be provided chemotherapy drugs free of cost. Speaking at a function held on the occasion at the Dr. B. Borooah Cancer Institute here, Mr. Gogoi said the government decided to provide …
DEBATE Eventually, the debate boils down to whether removing patent rights will lead to lower R&D; in diseases that are important for patients in developing economies. Ranjit Shahani Vice-Chairman & Managing Director, Novartis India Limited If people don't get a fair return in innovation, they won't invest in finding new …
In Africa, hard-hit by HIV, the proportion of TB drug-resistance is no less alarming. In former Soviet Union, almost half of all TB cases are resistant to at least one anti-TB drug -Bobby Ramakant This World Tuberculosis (TB) Day (24 March) is another opportunity for people of India to review …
Does putting full sets of clinical trial data in the public domain affect a company's commercial interest? It might. But does the public interest not outweigh this? Yes, because if the product is useless or harmful, there should be no commerce in it in the first place. The scientific study …
A Delhi High Court interim order given last week can totally alter the patent regime in the country for life-saving drugs. The court allowed Cipla to market Erlontinib , a medicine for lung cancer, though the Indian patent on the drug, Tarceva, is held by Roche of Switzerland. The court …
358 of 413 drug patent applications for the disease in India are from top multinationals. The recent legal reverses suffered by multinational majors Novartis and Roche over patents for cancer medicine could be the tip of a huge iceberg. A city-based policy research group has found that multinational drug firms …
A tuberculosis research expert today said the world urgently needs a new drug for TB to provide relief to the ailing patients. In a statement issued on the eve of the World TB Day, Dr Balganesh, head of research at AstraZeneca, said, "With new societal changes, impacting the immune system, …
All four districts of Tripura have become malaria drug resistant while the State Government has asked the Centre to provide help in combating vulnerability to the deadly disease. Replying to a calling attention in the State Assembly here today, State Health and Family Welfare Minister Tapan Chakraborty revealed that three …
Residue levels of drugs, pesticides and heavy metals in food commodities, is becoming a major concern for food regulators all over the world. Since the residue levels cannot be changed drastically through various production techniques and because it is necessary to provide safe food to the consumers, it is essential …
Even as nearly 4,000 people in the city are detected with tuberculosis every year, the numbers of those also resistant to drugs has increased over the years. To tackle the increasing problem of multi drug resistant tuberculosis (MDR-TB), the state government on World TB Day (March 24) has decided to …
Pfizer Inc, the world's largest pharmaceutical company, will soon initiate programmes to develop drugs specific to diseases in developing countries, such as India, moving away from its history of focusing on ailments prevalent in the US and Europe. "Our drug development activities in future will include drugs specific to regional …
With global pharma companies waking up to technology outsourcing services as a tool to reduce the time to market of their R&D; harvest, Accenture is looking at expanding the scope and scale of its lifescience centre of excellence in India. Accenture's life science R&D; centre in Bangalore is its largest …
THE second part of Frontline's interview with David Baltimore, the reputed American biologist and Nobel laureate, includes a discussion on a wide range of issues including his own research; funding in health-related research and development; the "moral conundrum' of high investments in product development by drug companies versus making drugs …
